在全球及中国生育率持续下降及人口结构变化的背景下，不孕不育问题逐渐成为重要公共健康议题。随着生殖医学技术进步及生育支持政策不断完善，辅助生殖技术（ART）正成为应对生育挑战的重要医疗解决方案。近年来，中国辅助生殖行业持续发展，持牌辅助生殖医疗机构数量不断增加，行业服务能力持续提升，辅助生殖技术在不孕不育人群中的渗透率亦逐步提高。
本报告从全球及中国市场出发，对辅助生殖行业的发展现状及未来趋势进行系统分析，并从取卵周期数规模、消费者品牌认知、临床技术能力、客户服务能力及国际化运营能力等多个维度，对主要行业参与者的市场地位及竞争格局进行综合评估，以刻画全球及中国辅助生殖行业的发展态势。
Against the backdrop of declining fertility rates and demographic shifts both globally and in China, infertility has gradually become an important public health issue. With continuous advancements in reproductive medicine and the ongoing improvement of fertility-supportive policies, assisted reproductive technology (ART) is increasingly becoming an important medical solution to address fertility challenges. In recent years, China’s assisted reproduction industry has continued to develop, with the number of licensed assisted reproductive medical institutions steadily increasing, overall service capacity improving, and the penetration rate of assisted reproductive technologies among infertile populations gradually rising.
This report analyzes the current development status and future trends of the assisted reproduction industry from both global and Chinese market perspectives. It evaluates the market position and competitive landscape of major industry participants across multiple dimensions, including egg retrieval cycle scale, consumer brand awareness, clinical technology capability, customer service capability, and international operation capability, in order to depict the development dynamics of the assisted reproduction industry in China and globally.
如果您对中国辅助生殖市场有进一步的研究需求，请联系我们：
沙利文 毛先生
E-mail: fred.mao@frostchina.com
